2024 Surgical Section Meeting: National Medical Association — On Demand

Tuesday, September 10, 2024, 7:55 AM - Tuesday, September 30, 2025, 11:00 PM

We're excited to offer a complimentary on-demand option for the Surgical Section Meeting from the 2024 National Medical Association's Annual Convention and Scientific Assembly, held on August 4, 2024 in New York City. This program highlights the latest advancements in surgical techniques and pivotal discussions on health equity across diverse communities. Through a series of dynamic presentations and insightful discussions, leading experts explore a diverse range of topics, including:

• The Evolution of Axillary Surgery for Breast Cancer: Highlighting the latest advancements in axillary surgery and their impact on treatment outcomes.
• Precision Therapy in Rectal Cancer: Exploring the frontier of precision medicine in rectal cancer treatment and its effects on patient quality of life.
• Genetics and Underrepresented Populations: Discussing the benefits of genetic testing for cancer susceptibility in diverse populations.
• Disaster Preparedness in Surgery: Learning essential protocols and strategies for surgical teams during emergencies.
• The Role of Women in Ensuring Community Health: Highlighting women's pivotal roles in healthcare leadership and community health advocacy.
• Equity in Surgical Residency: Addressing equity and diversity in surgical residency programs and initiatives for inclusive training environments.
• Artificial Intelligence and Technologies in Surgery: Discovering the impact of AI, robotics, and advanced technologies on surgical practices.

For a complete list of presentations and speakers, please refer to the brochure from the live meeting.

The mission of the Surgical Section of the National Medical Association (SS-NMA) is to stimulate, support and sustain, amongst all of its members, interest and excellence in all facets of the clinical practice of surgery.

1. Analyze the evolution of axillary surgery techniques, including their historical context, advancements, and impact on improving surgical outcomes and patient quality of life.
2. Evaluate the role of precision therapy (e.g., targeted therapies, personalized medicine) in the treatment of rectal cancer, assessing its efficacy and potential challenges.
3. Increase the representation of underrepresented minority populations in genetic testing for cancer susceptibility.
4. Examine and discuss disaster preparedness plans for surgical teams, ensuring readiness to respond effectively during emergencies and optimize patient outcomes.
5. Assess the contributions of women in healthcare leadership and community health, and strategize ways to enhance their role in promoting community health and equity.
6. Describe initiatives within surgical residency programs to promote diversity, inclusion, and equity, fostering a supportive environment for trainees from diverse backgrounds.
7. Evaluate the integration of artificial intelligence, robotics, and other advanced technologies in surgical practice, considering their impact on surgical precision, efficiency, and patient outcomes.

This on-demand offering is complimentary for all. To access the course materials, including instructions for claiming credit, please click the ‘Register’ tab above and complete the registration form. Once registered, you can find all the course materials under the ‘Course Content’ tab. Access to PDFs and videos, as well as the ability to claim credit, will be available until March 31, 2025.

Memorial Sloan Kettering Cancer Center is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

AMA Credit Designation Statement

Memorial Sloan Kettering Cancer Center designates this enduring material for a maximum of 6.50 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

ABS CC Recognition Statement

Successful completion of this CME activity, which includes participation in the evaluation component, enables the learner to earn 6.50 credits toward the CME and Self-Assessment requirement(s) of the American Board of Surgery’s Continuous Certification program. It is the CME activity provider's responsibility to submit learner completion information to ACCME for the purpose of granting ABS credit.

Please be advised that MOC points will be awarded approximately 45 days after the submission of your evaluation.

Recorded/Review Date: August 4, 2024 | Original Release Date: September 10, 2024 | Termination Date: March 31, 2025

MSK Course Director 

Carol L. Brown, MD, FACOG, FACS
Senior Vice President and Chief Health Equity Officer
Nicholls-Biondi Chair for Health Equity at Memorial Sloan Kettering
Vice Chair Health Equity, Department of Surgery

Invited Faculty 

Frederick Cason, MD 
Surgical Program Director 
San Joaquin General Hospital 

R. Derek Collier, MD, MBA, FACS, FCCM, FCCP 
Intensivist; 
Chair, Surgery Section, National Medical Association, 2023-2024 
Nashville, TN 

Wayne Frederick, MD, FACS
Charles R. Drew Professor of Surgery;
Former President, Howard University

Terrence M. Fullum, MD, MBA, FACS
Professor and Chair of Surgery
Howard University College of Medicine
Howard University Hospital

Keith Gray, MD, MBA, FACS
President and Chief Executive Officer
University of Tennessee Health System  

Shaneeta Johnson, MD, FACS
Professor of Surgery;
Program Director, General Surgery Program
Morehouse School of Medicine

Anita Johnson, MD, FACS
Chief of Surgery, City of Hope Atlanta
Leader of the Atlanta Women’s Cancer Center

KMarie King, MD, MS, MBA, FACS 
Henry and Sally Schaffer Chair; 
Chief of Surgery
Department of Surgery 
Albany Medical Center  

Jonathan Laryea, MD, FACS, FASCRS
Professor of Surgery;
Chief, Division of Colon & Rectal Surgery 
University of Arkansas for Medical Sciences (UAMS)

Emery Minnard, MD
Surgical Oncologist
Ochner Health Center

Erika Newman, MD, FACS
Associate Professor, Section Head of Pediatric Surgery;
Surgical Director, Mott Solid Tumor Oncology Program 
Michael W. Mulholland MD PhD Research Professor 
University of Michigan

Jessica N. Rea, MD
Vascular Surgeon
Mid-Atlantic Permanente Medical Group

Yara Robertson, MD, FACS 
Medical Director of Surgical Oncology 
CARTI Cancer Center 

John Stewart, IV, MD, MBA, FACS
Chair, Department of Surgery;
Chief of Surgery, Morehouse School of Medicine at Grady Health; 
System Associate Dean for Oncological Programs, 
Morehouse School of Medicine

Erica Sutton, MD, FACS
Senior Associate Dean, Undergraduate Medical Education;
Associate Professor of Surgery
Morehouse School of Medicine 

Hassan Tetteh, MD, MBA, FACS, FACHE
Retired U.S. Navy Captain;
Associate Professor
Uniformed Services University of the Health Sciences

Jeffrey Upperman, MD, FACS
Professor and Chair Department of Pediatric Surgery
Vice Chair, Pediatric Surgical Services 
Vanderbilt University
Surgeon-in-Chief, Monroe Carell Jr. Children’s Hospital

Mallory Williams, MD, MPH, FACS
Chair, Department of Trauma and Burn
John H. Stroger Jr., Hospital of Cook County

James Williams, Jr 
Director of Federal Relations  
American Cancer Society  

 

MSK Leadership Welcome 

Jeffrey Drebin, MD, PhD
Chair, Department of Surgery
Murray F. Brennan Chair in Surgery

Selwyn M. Vickers, MD, FACS
President and Chief Executive Officer

MSK Faculty

Fiyinfolu Balogun, MD, PhD
Assistant Attending
Gastrointestinal Oncology Service
Department of Medicine

Tracy-Ann Moo, MD
Associate Attending
Breast Service
Department of Surgery

Anaeze Offodile II, MD, MPH
Executive Vice President;
Chief Strategy Officer

J. Joshua Smith, MD, PhD, FACS
Associate Attending 
Colorectal Service
Department of Surgery

 

View relevant financial relationships as of the program date, August 4, 2024. 

Mitigation of Relevant Financial Relationships

Memorial Sloan Kettering Cancer Center adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a CE activity, including faculty, planners, reviewers, or others are required to disclose all financial relationships with ineligible companies (commercial interests). All relevant financial relationships have been mitigated prior to the commencement of the activity.